Hyperandrogenism insulin resistance-acanthosis nigricans syndrome in a female adolescent with migraine: A case report
Abstract
The case study explores the extreme manifestation of polycystic ovary syndrome known as hyperandrogenism insulin resistance-acanthosis nigricans (HAIR-AN) syndrome in patients with migraine, which is marked by hyperandrogenism (HA), insulin resistance (IR) and acanthosis nigricans (AN). Typically affecting women during their reproductive years, with a higher prevalence observed among adolescents, HAIR-AN syndrome’s aetiology is multifaceted, involving genetic and environmental factors, including the related seborrhoea, acne, hirsutism and alopecia syndrome. The report details the case of an 18-year-old female presenting with HAIR-AN syndrome, demonstrating symptoms such as migraine, obesity, acne, hirsutism and AN, which manifested during puberty. Despite symptom onset in adolescence, diagnosis was delayed until adulthood. Clinical evaluation revealed obesity, HA and IR, with laboratory tests confirming diabetes. The case suggests a potential link between IR-induced diabetes and the development of migraine symptoms. Treatment encompasses a multifaceted approach involving antiandrogen therapy, weight management strategies, migraine treatment and medications such as metformin used to address IR and orlistat, targeting obesity. Emphasis is placed on the significance of early diagnosis and intervention in endocrine disorders with HA to enhance treatment efficacy. The complex interplay between hormonal and metabolic dysregulation in HAIR-AN syndrome is highlighted, advocating for…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.